The invention relates generally to the changes in gene expression in hepatocellular carcinoma. The invention relates specifically to human genes that correspond to mRNA species that are differentially expressed in cancerous liver tissue and in cancerous neoplasms compared to non-cancerous liver tissue.

 
Web www.patentalert.com

< Compounds for modulating the activity of exchange proteins directly activated by camp (epacs)

< Configuration of glycosaminoglycans

> Carboxylic acid diesters, methods for the production thereof and methods for the production of pharmaceutical active substances coupled to free amino groups with polysaccharide or polysaccharide derivatives

> Novel substitution mutant receptors and their use in an nuclear receptor-based inducible gene expression system
~ 00297